The unprecedented weight loss for an anti-obesity medication marks a new era in the treatment of obesity, and we now look forward to making Wegovy available to people living with obesity in the U.S. Novo Nordisk plans to launch the drug in the U.S
It's predictable endocrinology
Nausea, vomiting, diarrhea, and/or constipation are all common complaints of GLP-1 drugs due to slow gastric emptying
However, later it was reported that in both nonmammals and mammals, PACAP and GHRH are encoded in different genes (169)
If the sources of inflammation gut dysbiosis, visceral fat, chronic stress, poor diet have not been addressed, inflammation resumes driving weight gain